What is LinkBio?
Headquartered in Hamburg, LinkBio operates at the intersection of precision engineering and patient-centric healthcare. The company specializes in the design and manufacture of high-quality joint replacement solutions, covering hip, knee, and upper extremity applications. With a legacy spanning over five decades, the organization maintains a rigorous focus on quality control and manufacturing excellence. Their market presence extends across more than 70 countries, where they provide surgeons and healthcare providers with innovative tools designed to restore mobility and improve patient outcomes. The firm's dedication to professional training and clinical innovation remains a cornerstone of its operational strategy.
How much funding has LinkBio raised?
LinkBio has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in LinkBio
PPP
Public-Private Partnership
What's next for LinkBio?
With the successful completion of this late-stage financing, LinkBio is well-positioned to accelerate its international expansion and deepen its research and development pipeline. The strategic allocation of this capital will likely focus on scaling production capabilities to meet the rising global demand for advanced arthroplasty solutions. Furthermore, the company is expected to continue its investment in educational initiatives, ensuring that the next generation of orthopedic specialists is equipped with the latest prosthetic technologies. By maintaining its focus on bioharmonious design and clinical efficacy, LinkBio is poised to sustain its growth trajectory within the competitive medical device landscape.
See full LinkBio company page
